Differences between acute‐onset chronic inflammatory demyelinating polyneuropathy and acute inflammatory demyelinating polyneuropathy in adult patients
- 25 March 2018
- journal article
- research article
- Published by Wiley in Journal of the Peripheral Nervous System
- Vol. 23 (3) , 154-158
Abstract
Acute inflammatory demyelinating polyneuropathy (AIDP) and acute‐onset chronic inflammatory demyelinating polyneuropathy (A‐CIDP) are conditions presenting overlapping clinical features during early stages (first 4 weeks), although the latter may progress after 8 weeks. The aim of this study was to identify predictive factors contributing to their differential diagnosis. Clinical records of adult patients with AIDP or A‐CIDP diagnosed at our institution between January 2006 and July 2017 were retrospectively reviewed. Demographic characteristics, clinical manifestations, cerebrospinal‐fluid (CSF) findings, treatment and clinical evolution were analyzed. Nerve conduction studies were performed in all patients with at least 12 months follow‐up. A total of 91 patients were included (AIDP, n = 77; A‐CIDP, n = 14). The median age was 55.5 years in patients with A‐CIDP vs 43 years in AIDP (P = .07). The history of diabetes mellitus was more frequent in A‐CIDP (29% vs 8%, P = .04). No significant differences between groups were observed with respect to: human immunodeficiency virus (HIV) status, presence of auto‐immune disorder or oncologic disease. Cranial, motor and autonomic nerve involvement rates were similar in both groups. Patients in the A‐CIDP group showed higher frequency of proprioceptive disturbances (83% vs 28%; P < .001), sensory ataxia (46% vs 16%; P = .01), and the use of combined immunotherapy with corticoids (29% vs 3%; P = .005). There were no significant differences in CSF findings, intensive care unit (ICU) admission, or mortality rates. During the first 8 weeks both entities are practically indistinguishable. Alterations in proprioception could suggest A‐CIDP. Searching for markers that allow early differentiation could favor the onset of corticotherapy without delay.Keywords
This publication has 22 references indexed in Scilit:
- Autonomic dysfunction in chronic inflammatory demyelinating polyradiculoneuropathyNeurology, 2012
- Distinguishing acute-onset CIDP from fluctuating Guillain-Barré syndromeNeurology, 2010
- Clinical and electrophysiological parameters distinguishing acute‐onset chronic inflammatory demyelinating polyneuropathy from acute inflammatory demyelinating polyneuropathyMuscle & Nerve, 2009
- Electrodiagnostic criteria for acute and chronic inflammatory demyelinating polyradiculoneuropathyMuscle & Nerve, 2004
- Electrophysiological classification of guillain‐barré syndrome: Clinical associations and outcomeAnnals of Neurology, 1998
- Chronic dysimmune demyelinating polyneuropathy: a clinical and electrophysiological study of 93 patients.Journal of Neurology, Neurosurgery & Psychiatry, 1996
- Interobserver agreement in the assessment of muscle strength and functional abilities in Guillain‐Barré syndromeMuscle & Nerve, 1991
- Treatment related fluctuations in Guillain-Barre syndrome after high-dose immunoglobulins or plasma-exchange.Journal of Neurology, Neurosurgery & Psychiatry, 1991
- Chronic inflammatory demyelinating polyneuropathy of infancy: A corticosteroid‐responsive disorderAnnals of Neurology, 1986
- Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathyMuscle & Nerve, 1985